Comparing the outcomes of noninferiority (NI) and superiority phase III trials.

被引：0
|
作者：
Saad, Everardo D.
Buyse, Marc E.
机构：
[1] Dendrix Res, Sao Paulo, Brazil
[2] Int Inst Drug Dev, Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13055
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Noninferiority (NI) phase III trials in oncology: What is the basis for choosing the NI margin?
    Militao, M. S.
    Saad, E. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Understanding superiority, noninferiority, and equivalence for clinical trials
    Kishore, Kamal
    Mahajan, Rahul
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (06) : 890 - 894
  • [3] Designs of superiority and noninferiority trials for binary responses are noninterchangeable
    Hilton, Joan F.
    BIOMETRICAL JOURNAL, 2006, 48 (06) : 934 - 947
  • [4] Noninferiority (NI) Phase III Trials in Advanced Breast Cancer (ABC) over 12 Years.
    Saad, E. D.
    Militao, M. S.
    CANCER RESEARCH, 2011, 71
  • [5] Performance status restriction in phase III cancer clinical trials.
    Kouzy, Ramez
    Jaoude, Joseph Abi
    Mainwaring, Walker
    Lin, Timothy
    Miller, Austin B.
    Jethanandani, Amit
    Espinoza, Andres F.
    Taniguchi, Cullen M.
    Ludmir, Ethan B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Population pharmacokinetics of rosiglitazone (R) in phase III clinical trials.
    Patel, BR
    Diringer, K
    Conrad, J
    Miller, A
    Rappaport, E
    Boyle, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 123 - 123
  • [7] Considerations for Design and Data Analysis of Noninferiority/Superiority Cardiovascular Trials
    Quan, Hui
    Li, Mingyu
    Zhao, Peng-Liang
    Cho, Meehyung
    Zhang, Ji
    Wu, Yujun
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (01) : 239 - 260
  • [8] The impact of covariate adjustment at randomization and analysis for binary outcomes: understanding differences between superiority and noninferiority trials
    Nicholas, Katherine
    Yeatts, Sharon D.
    Zhao, Wenle
    Ciolino, Jody
    Borg, Keith
    Durkalski, Valerie
    STATISTICS IN MEDICINE, 2015, 34 (11) : 1834 - 1840
  • [9] Unifying Design and Analysis for Superiority and Noninferiority Trials With Appropriate End Point
    Claggett, Brian
    Uno, Hajime
    Wei, Lee-Jen
    JAMA SURGERY, 2019, 154 (05) : 466 - 467
  • [10] Characterizing discontinuation and withdrawal from phase III oncology clinical trials.
    Malhi, Navraj
    Gresham, Gillian
    Eigl, Bernhard J.
    Grant, Janice
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345